How and When to Use Vaccine Serology to Confirm Protection and Avoid Overvaccination

Live Webinar  ┃  Tuesday 3rd November  ┃  7:30pm GMT

Talk Summary

Should you be titer testing before vaccinations?

In this live webinar from Nathaniel Whitley, we will be discussing how protection against some diseases can be assessed by serology using patient-side tests or gold-standard laboratory assays. You will discover how antibody testing can help confirm when a puppy or kitten has completed its primary vaccine course, determine whether an adult pet truly needs revaccination, and support difficult decisions for patients with immune-mediated disease or those receiving immunosuppressive treatment.

This practical session will show how serological testing can help vets balance protection with risk, avoid unnecessary vaccination and deliver safer, evidence-led patient care.

Register Now to Watch Live

Complete the form below to register for this FREE webinar:

What You'll Learn

  • The role and limitations of serological testing in determining protective immunity using patient side tests and/or gold-standard laboratory tests

  • Understand the challenges posed by long-duration maternally derived antibody and how serological testing can help establish when the primary vaccination course is complete

  • Know how serological testing can be used to reduce the number and frequency of booster vaccines given to healthy adult pets

  • Recognise situations where serological testing can help vaccination decisions in pets at risk from relapse of immune-mediated disease, or those receiving long-term immunosuppressants.

Meet the Speaker

Nathaniel Whitley
BVMS, PhD, CertVC, DACVIM, DECVIM-Ca, FRCVS

Nathaniel graduated from Glasgow in 1992 and pursued specialist training in USA, becoming board certified in internal medicine, before completing an immunology PhD in Bristol. He has worked as a small animal medicine specialist at Davies Veterinary Specialists since 2004.

Latterly he has been subject matter expert for vaccines and immunology on the Clinical Boards of Linnaeus and then Mars Veterinary Health Europe, and has been a member of the WSAVA Vaccination Committee since 2020. His main interests are immune-mediated disease, adverse reactions to vaccines, rational vaccination practices and vaccination hesitancy.

Biogal Labs is a veterinary diagnostics company specializing in point-of-care solutions for companion animals.

Since 1984, Biogal has developed diagnostic platforms for infectious diseases, serology, and molecular testing, supporting veterinarians in making faster and more informed clinical decisions. 

Biogal is the manufacturer of VacciCheck, an in-clinic antibody titer test designed to assess immune response to core vaccines. For dogs, VacciCheck measures antibodies to canine parvovirus, canine distemper virus, and canine adenovirus, while the feline test evaluates antibodies to feline panleukopenia virus, feline herpesvirus and feline calicivirus. 

VacciCheck helps veterinarians confirm vaccine response and assess existing immunity, supporting more individualized vaccination decisions. The test is used internationally in veterinary clinics, laboratories, shelters, and research settings. 

VacciCheck is available to UK practices through Nextmune UK Laboratories.